TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Getinge ( ($SE:GETI.B) ) just unveiled an update.
Getinge has announced its Q2 Report 2025 will be released on July 18, 2025, followed by a conference call hosted by the company’s President & CEO and CFO. This event invites fund managers, analysts, and media to participate, potentially impacting stakeholders by providing insights into the company’s financial performance and strategic direction.
The most recent analyst rating on ($SE:GETI.B) stock is a Sell with a SEK190.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.
More about Getinge
Getinge is a company that provides hospitals and life science institutions with products and solutions aimed at improving clinical results and optimizing workflows. Their offerings include products for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science. Getinge employs approximately 12,000 people worldwide and sells its products in 135 countries.
Average Trading Volume: 868,341
Current Market Cap: SEK53.02B
Find detailed analytics on GETI.B stock on TipRanks’ Stock Analysis page.